New initiative will collect pharma and CRO data to refine industry carbon measurement of technologies The post Pistoia Alliance Launches Initiative to Assess Sustainability of Digital vs. Traditional Clinical Trial Approaches appeared first on Pistoia Alliance.| Pistoia Alliance
Volume is up but value is down. That’s the headline of the dealmaking scene for the first half of 2024. There’s not been a mega-merger in the vein of 2023’s Pfizer/Seagen deal, though the Novo/Catalent deal aimed at boosting supplies of the semaglutide products Ozempic and Wegovy is certainly notable. Even so, the 18% increase […] The post 2024 Dealmaking: What’s the Score? appeared first on Evaluate.| Evaluate
If you missed our recent webinar, AI and ML in Pharma: Redefining the Forecasting Landscape, then I hope it’s because you were on a lovely vacation somewhere. Now that you’re back, though, you’ll be delighted to know that it’s available on demand so you can catch up at your leisure. Our panel, which included Daniel […] The post In Case You Missed It: Three Things we Learned in our AI Forecasting Webinar appeared first on Evaluate.| Evaluate
Buzzwords in the life sciences industry – there are many: Artificial Intelligence (AI), Gen AI, Machine Learning (ML), digital health, and real-world data (RWD)/real world evidence (RWE). All are vast, complex areas with notable potential to impact our clients and the industry overall – across the continuum of the product lifecycle, spanning clinical and commercial […] The post Knowledge and Insights: The Power of Real-World Data appeared first on Evaluate.| Evaluate
All parts of the pharma ecosystem are touched by speculation about AI. From drug discovery to clinical trials.| Evaluate